309 results
Page 11 of 16
8-K
EX-99.1
zqg3m9v 89
12 Dec 11
BioTime Successfully Completes HyStem®-Rx Preclinical ISO 10993 Studies
12:00am
8-K
EX-99.1
3nyzqd5sw3468fv t4oj
29 Nov 11
BioTime, Inc. Appoints Andrew C. von Eschenbach, M.D. to its Board of Directors
12:00am
8-K
EX-99.1
nvqsph aog4u
8 Nov 11
BioTime Announces Third Quarter 2011 Financial Results and Recent Corporate Accomplishments
12:00am
8-K
EX-99.1
q5g3cw7q 3yrs
25 Oct 11
BioTime CEO Michael D. West to Present Keynote Address at Translational Strategies for Tissue Engineering Conference
12:00am
8-K
EX-99.1
wwogxclb
13 Oct 11
BioTime Publishes Paper Describing First Complete Sequencing of the Nuclear DNA of Five Clinical-Grade Human Embryonic Stem Cell Lines
12:00am
8-K
EX-99.1
m5b3c atmrkpp1
11 Oct 11
BioTime CEO Michael D. West to Present at GTC 2011 5th Advances in Stem Cell Discovery & Development Conference
12:00am
8-K
EX-99.1
ghxszcq 4m
4 Oct 11
BioTime Announces Appointment of Chief Financial Officer
12:00am
8-K
EX-99.1
scww30zhavgr
12 Sep 11
BioTime CEO Michael D. West to Present at Stem Cells USA & Regenerative Medicine Congress 2011
12:00am
8-K
EX-99.1
93utrfp8gj8rr6g472
6 Sep 11
Entry into a Material Definitive Agreement
12:00am
8-K
schl2
6 Sep 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
d95gw
24 Aug 11
Capital to be utilized in advancing the development of novel cancer diagnostic and therapeutic products
12:00am
8-K
EX-99.1
dne6c
19 Aug 11
BioTime Receives NIH Approval for Four GMP Human Embryonic Stem Cell Lines
12:00am
8-K
EX-99.1
df9ob5we
10 Aug 11
BioTime Announces Second Quarter 2011 Financial Results and Corporate Developments
12:00am
8-K
EX-99.1
ggnii5ayrcllx7fhh
19 Jul 11
BioTime Announces the Issuance of a Second U.S. Glycosan Hydrogel Patent
12:00am
8-K
EX-99.1
mxt ndspy
15 Jul 11
BioTime Receives $335,900 SBIR Grant
12:00am
8-K
EX-99.1
0llch86zla pj
29 Jun 11
BioTime Announces Appointment of Chief Commercial Officer
12:00am